This study has demonstrated that high-dose CS-DMY-NPs significantly regulated the release of IL-1β, TNF-α, and IL-6 in the kidneys of mice, suggesting that DMY may attenuate LPS-induced acute kidney inflammation injury. Here, IL6 is linked to nephritis.